Parel JM - Search Results

1

Evaluating in vivo delivery of riboflavin with coulomb-controlled iontophoresis for corneal collagen cross-linking: a pilot study.

Arboleda A, Kowalczuk L, Savoldelli M, Klein C, Ladraa S, Naud MC, Aguilar MC, Parel JM, Behar-Cohen F. Arboleda A, et al. Among authors: parel jm. Invest Ophthalmol Vis Sci. 2014 Apr 28;55(4):2731-8. doi: 10.1167/iovs.14-13931. Invest Ophthalmol Vis Sci. 2014. PMID: 24667860

2

Keratoprosthesis with biocolonizable microporous fluorocarbon haptic. Preliminary results in a 24-patient study.

Legeais JM, Renard G, Parel JM, Savoldelli M, Pouliquen Y. Legeais JM, et al. Among authors: parel jm. Arch Ophthalmol. 1995 Jun;113(6):757-63. doi: 10.1001/archopht.1995.01100060083038. Arch Ophthalmol. 1995. PMID: 7786218 Clinical Trial.

3

Ultraviolet solid-state laser (213-nm) photorefractive keratectomy. In vivo study.

Ren Q, Simon G, Legeais JM, Parel JM, Culbertson W, Shen J, Takesue Y, Savoldelli M. Ren Q, et al. Among authors: parel jm. Ophthalmology. 1994 May;101(5):883-9. doi: 10.1016/s0161-6420(94)31243-7. Ophthalmology. 1994. PMID: 8190475 Free article.

4

Iontophoresis of dexamethasone in the treatment of endotoxin-induced-uveitis in rats.

Behar-Cohen FF, Parel JM, Pouliquen Y, Thillaye-Goldenberg B, Goureau O, Heydolph S, Courtois Y, De Kozak Y. Behar-Cohen FF, et al. Among authors: parel jm. Exp Eye Res. 1997 Oct;65(4):533-45. doi: 10.1006/exer.1997.0364. Exp Eye Res. 1997. PMID: 9464186 Free article.

5

Reduction of corneal edema in endotoxin-induced uveitis after application of L-NAME as nitric oxide synthase inhibitor in rats by iontophoresis.

Behar-Cohen FF, Savoldelli M, Parel JM, Goureau O, Thillaye-Goldenberg B, Courtois Y, Pouliquen Y, de Kozak Y. Behar-Cohen FF, et al. Among authors: parel jm. Invest Ophthalmol Vis Sci. 1998 May;39(6):897-904. Invest Ophthalmol Vis Sci. 1998. PMID: 9579469

6

Novel synthetic meshwork for glaucoma treatment. I. Design and preliminary in vitro and in vivo evaluation of various expanded poly(tetrafluoroethylene) materials.

Jallet V, Gautier SE, Parel JM, Matsui T, Haefliger I, Kondo H, Kato H, Savoldelli M, Pouliquen Y. Jallet V, et al. Among authors: parel jm. J Biomed Mater Res. 1999 Nov;47(2):260-9. doi: 10.1002/(sici)1097-4636(199911)47:2<260::aid-jbm17>3.0.co;2-j. J Biomed Mater Res. 1999. PMID: 10449638

7

[Iontophoresis: past and future].

Behar-Cohen F, El Aouni A, Le Rouic JF, Parel JM, Renard G, Chauvaud D. Behar-Cohen F, et al. Among authors: parel jm. J Fr Ophtalmol. 2001 Mar;24(3):319-27. J Fr Ophtalmol. 2001. PMID: 11285450 Review. French. No abstract available.

8

Lontophoresis for the treatment of paecilomyces keratitis.

Yoo SH, Dursun D, Dubovy S, Miller D, Alfonso E, Forster RK, Behar-Cohen F, Parel JM. Yoo SH, et al. Among authors: parel jm. Cornea. 2002 Jan;21(1):131-2. doi: 10.1097/00003226-200201000-00029. Cornea. 2002. PMID: 11805526 No abstract available.

9

Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.

Behar-Cohen FF, El Aouni A, Gautier S, David G, Davis J, Chapon P, Parel JM. Behar-Cohen FF, et al. Among authors: parel jm. Exp Eye Res. 2002 Jan;74(1):51-9. doi: 10.1006/exer.2001.1098. Exp Eye Res. 2002. PMID: 11878818

10

Ocular aspirin distribution: a comparison of intravenous, topical, and coulomb-controlled iontophoresis administration.

Voigt M, Kralinger M, Kieselbach G, Chapon P, Anagnoste S, Hayden B, Parel JM. Voigt M, et al. Among authors: parel jm. Invest Ophthalmol Vis Sci. 2002 Oct;43(10):3299-306. Invest Ophthalmol Vis Sci. 2002. PMID: 12356838

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

285 results

Search Page

Filters